PMID- 29782068 OWN - NLM STAT- MEDLINE DCOM- 20190919 LR - 20190919 IS - 2042-6984 (Electronic) IS - 2042-6976 (Linking) VI - 8 IP - 9 DP - 2018 Sep TI - Comparison of outcomes following culture-directed vs non-culture-directed antibiotics in treatment of acute exacerbations of chronic rhinosinusitis. PG - 1028-1033 LID - 10.1002/alr.22147 [doi] AB - BACKGROUND: Acute exacerbations in patients with chronic rhinosinusitis (CRS) are often treated with courses of systemic antibiotics. Poor correlation between microbiologic culture results and the sinus microbiome in CRS has caused increased debate as to the relevance of culture-directed antibiotics. There is currently sparse data comparing outcomes of culture-directed antibiotics vs non-culture-directed antibiotics for treatment of CRS. METHODS: This work reports a retrospective review. A total of 946 CRS patients treated with antibiotics were examined; 122 CRS patients with acute exacerbations were treated with culture-directed (n = 61) vs empiric (n = 61) antibiotics. Lund-Kennedy (LK) and 22-item Sino-Nasal Outcome Test (SNOT-22) scores were compared pretreatment and posttreatment, with short-term (<1 month) and long-term (1-6 months) follow-up. Patient demographics, comorbidities, and prior surgical history were collected. RESULTS: Both groups had similar pretreatment SNOT-22 scores (p = 0.25) while the culture group had higher baseline LK endoscopy scores (p < 0.01). All data were adjusted for pertinent comorbidities, surgical history, co-therapeutics, and baseline scores. There was no difference in improvement in culture-directed and empirically treated groups in the short-term (p = 0.77) and long-term (p = 0.58) for minimal clinically important difference (MCID) of SNOT-22 and no difference in the short-term for LK scores (p = 0.11), but there was significantly more improvement in long-term LK scores in the culture-directed group (p = 0.01). CONCLUSION: Culture-directed therapy improves long-term endoscopy scores but does not yield an advantage in improving short-term endoscopy scores, nor in improving short-term and long-term quality of life scores in CRS patients. A prospective study is necessary to examine the relevance of routine microbiologic cultures in CRS patients. CI - (c) 2018 ARS-AAOA, LLC. FAU - Yan, Carol H AU - Yan CH AUID- ORCID: 0000-0003-1934-4922 AD - Department of Otolaryngology-Head and Neck Surgery, Stanford University, Stanford, CA. FAU - Tangbumrungtham, Navarat AU - Tangbumrungtham N AD - Department of Otolaryngology-Head and Neck Surgery, Stanford University, Stanford, CA. AD - Department of Otorhinolaryngology, Ramathibodi Hospital, Bangkok, Thailand. FAU - Maul, Ximena A AU - Maul XA AD - Department of Otolaryngology-Head and Neck Surgery, Stanford University, Stanford, CA. AD - Department of Otolaryngology, Pontificia Universidad Catolica de Chile, Santiago, Chile. FAU - Ma, Yifei AU - Ma Y AD - Department of Otolaryngology-Head and Neck Surgery, Stanford University, Stanford, CA. FAU - Nayak, Jayakar V AU - Nayak JV AD - Department of Otolaryngology-Head and Neck Surgery, Stanford University, Stanford, CA. FAU - Hwang, Peter H AU - Hwang PH AD - Department of Otolaryngology-Head and Neck Surgery, Stanford University, Stanford, CA. FAU - Patel, Zara M AU - Patel ZM AUID- ORCID: 0000-0003-2072-982X AD - Department of Otolaryngology-Head and Neck Surgery, Stanford University, Stanford, CA. LA - eng PT - Comparative Study PT - Journal Article DEP - 20180521 PL - United States TA - Int Forum Allergy Rhinol JT - International forum of allergy & rhinology JID - 101550261 RN - 0 (Anti-Bacterial Agents) SB - IM MH - Adult MH - Aged MH - Anti-Bacterial Agents/*therapeutic use MH - Bacteria/*isolation & purification MH - Chronic Disease MH - Drug Utilization Review MH - Endoscopy MH - Female MH - Humans MH - Male MH - Middle Aged MH - Paranasal Sinuses/microbiology/pathology/surgery MH - Quality of Life MH - Retrospective Studies MH - Rhinitis/*diagnosis/*drug therapy/pathology/surgery MH - Sinusitis/*diagnosis/*drug therapy/pathology/surgery MH - Time Factors MH - Treatment Outcome OTO - NOTNLM OT - Lund-Kennedy OT - SNOT-22 OT - antibiotic OT - chronic rhinosinusitis OT - culture OT - exacerbation OT - infection OT - quality of life OT - therapeutics EDAT- 2018/05/22 06:00 MHDA- 2019/09/20 06:00 CRDT- 2018/05/22 06:00 PHST- 2018/03/03 00:00 [received] PHST- 2018/04/23 00:00 [revised] PHST- 2018/05/03 00:00 [accepted] PHST- 2018/05/22 06:00 [pubmed] PHST- 2019/09/20 06:00 [medline] PHST- 2018/05/22 06:00 [entrez] AID - 10.1002/alr.22147 [doi] PST - ppublish SO - Int Forum Allergy Rhinol. 2018 Sep;8(9):1028-1033. doi: 10.1002/alr.22147. Epub 2018 May 21.